Cargando…

Xenogeneic equine stem cells activate anti-tumor adaptive immunity in a 4T1-based intraductal mouse model for triple-negative breast cancer: proof-of-principle

Triple-negative breast cancer (TNBC) remains difficult to treat, especially due to ineffective immune responses. Current treatments mainly aim at a cytotoxic effect, whereas (stem) cell therapies are being investigated for their immune stimulatory capacities to initiate the anti-tumor immunity. Here...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steenbrugge, Jonas, Pauwelyn, Glenn, Demeyere, Kristel, Devriendt, Nausikaa, de Rooster, Hilde, Sanders, Niek N., Spaas, Jan H., Meyer, Evelyne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623058/ https://www.ncbi.nlm.nih.gov/pubmed/37928528 http://dx.doi.org/10.3389/fimmu.2023.1252374

Ejemplares similares

Homing of radiolabelled xenogeneic equine peripheral blood-derived MSCs towards a joint lesion in a dog
por: Beerts, Charlotte, et al.
Publicado: (2022)

Comparative Profiling of Metastatic 4T1- vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer
por: Steenbrugge, Jonas, et al.
Publicado: (2019)

Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer
por: Steenbrugge, Jonas, et al.
Publicado: (2018)

OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer
por: Steenbrugge, Jonas, et al.
Publicado: (2021)

One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer
por: Steenbrugge, Jonas, et al.
Publicado: (2022)

Repeated specific canine pancreatic lipase measurements do not identify multiple acquired portosystemic shunts in dogs after extrahepatic portosystemic shunt attenuation
por: Serrano, Gonçalo, et al.
Publicado: (2023)

Comparison of diet, lactulose, and metronidazole combinations in the control of pre‐surgical clinical signs in dogs with congenital extrahepatic portosystemic shunts
por: Serrano, Goncalo, et al.
Publicado: (2022)

Treatment of congenital extrahepatic portosystemic shunts in dogs: A systematic review and meta‐analysis
por: Serrano, Gonçalo, et al.
Publicado: (2019)

Persistent hypercobalaminemia three months after successful gradual attenuation of extrahepatic shunts in dogs: a prospective cohort study
por: Devriendt, Nausikaa, et al.
Publicado: (2022)

B-Mode and Contrast-Enhanced Ultrasonography Aspects of Benign and Malignant Superficial Neoplasms in Dogs: A Preliminary Study
por: Hillaert, Amber, et al.
Publicado: (2022)

Plasma amino acid profiles in dogs with closed extrahepatic portosystemic shunts are only partially improved 3 months after successful gradual attenuation
por: Devriendt, Nausikaa, et al.
Publicado: (2021)

Shear wave elastography measurements in dogs treated surgically for congenital extrahepatic portosystemic shunts
por: Toom, Merle, et al.
Publicado: (2022)

Flow cytometry, a powerful novel tool to rapidly assess bacterial viability in metal working fluids: Proof-of-principle
por: Vanhauteghem, Donna, et al.
Publicado: (2019)

Preconditioning with Lipopolysaccharide or Lipoteichoic Acid Protects against Staphylococcus aureus Mammary Infection in Mice
por: Breyne, Koen, et al.
Publicado: (2017)

Evaluation of serum lidocaine/monoethylglycylxylidide concentration to assess shunt closure in dogs with extrahepatic portosystemic shunts
por: Devriendt, Nausikaa, et al.
Publicado: (2021)

Scintigraphic tracking of (99m)Technetium-labelled equine peripheral blood-derived mesenchymal stem cells after intravenous, intramuscular, and subcutaneous injection in healthy dogs
por: Beerts, Charlotte, et al.
Publicado: (2021)

Low-dose xenogeneic mesenchymal stem cells target canine osteoarthritis through systemic immunomodulation and homing
por: Beerts, Charlotte, et al.
Publicado: (2023)

Review: Mesenchymal Stem Cell Therapy in Canine Osteoarthritis Research: “Experientia Docet” (Experience Will Teach Us)
por: Brondeel, Carlien, et al.
Publicado: (2021)

Immortalised canine buccal epithelial cells’ CXCL8 secretion is affected by allergen extracts, Toll-like receptor ligands, IL-17A and calcitriol
por: Pelst, Michael, et al.
Publicado: (2022)

Immunomodulation of Host Chitinase 3-Like 1 During a Mammary Pathogenic Escherichia coli Infection
por: Breyne, Koen, et al.
Publicado: (2018)

Immunogenicity and safety of xenogeneic vascular endothelial growth factor receptor-2 DNA vaccination in mice and dogs
por: Denies, Sofie, et al.
Publicado: (2016)

Principles of equine dentistry /
por: Klugh, David O.
Publicado: (2010)

Xenogenic Implantation of Equine Synovial Fluid-Derived Mesenchymal Stem Cells Leads to Articular Cartilage Regeneration
por: Zayed, Mohammed, et al.
Publicado: (2018)

Preliminary safety and imaging efficacy of the near-infrared fluorescent contrast agent DA364 during fluorescence-guided surgery in dogs with spontaneous superficial tumors
por: Favril, Sophie, et al.
Publicado: (2020)

Non-Classical ProIL-1beta Activation during Mammary Gland Infection Is Pathogen-Dependent but Caspase-1 Independent
por: Breyne, Koen, et al.
Publicado: (2014)

Identification by mass spectrometry and immunoblotting of xenogeneic antigens in the N- and O-glycomes of porcine, bovine and equine heart tissues
por: Jin, Chunsheng, et al.
Publicado: (2020)

AO principles of equine osteosynthesis /
Publicado: (2000)

Xenogenic Adenoviral Vectors
por: Mittal, Suresh K., et al.
Publicado: (2016)

Xenogenic Adenoviral Vectors
por: Both, Gerald W.
Publicado: (2002)

The use of equine chondrogenic‐induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double‐blinded, placebo‐controlled proof‐of‐concept study
por: Broeckx, S. Y., et al.
Publicado: (2019)

Comparison between xenogeneic and allogeneic adipose mesenchymal stem cells in the treatment of acute cerebral infarct: proof of concept in rats
por: Gutiérrez-Fernández, María, et al.
Publicado: (2015)

Adjuvanting Allergen Extracts for Sublingual Immunotherapy: Calcitriol Downregulates CXCL8 Production in Primary Sublingual Epithelial Cells
por: Pelst, Michael P., et al.
Publicado: (2020)

The effects of equine peripheral blood stem cells on cutaneous wound healing: a clinical evaluation in four horses
por: Spaas, J H, et al.
Publicado: (2013)

Effect of laboratory and sample storage factors on urinary protein:creatinine ratios and clinical decision making in cats
por: Mortier, Femke, et al.
Publicado: (2023)

Xenogeneic Silencing and Bacterial Genome Evolution: Mechanisms for DNA Recognition Imply Multifaceted Roles of Xenogeneic Silencers
por: Duan, Bo, et al.
Publicado: (2021)

Antiangiogenesis in recurrent glioblastoma: proof of principle
por: Nossek, Erez, et al.
Publicado: (2009)

Gamma Factory Proof-of-Principle Experiment
por: Krasny, M W, et al.
Publicado: (2019)

An in vitro proof-of-principle study of sonobactericide
por: Lattwein, Kirby R., et al.
Publicado: (2018)

Flow Cytometric Assessment of the Viability and Functionality of Uterine Polymorphonuclear Leukocytes in Postpartum Dairy Cows
por: Lietaer, Leen, et al.
Publicado: (2021)

Urinary chitinase 3-like protein 1 for early diagnosis of acute kidney injury: a prospective cohort study in adult critically ill patients
por: De Loor, Jorien, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m2900iossqe7l132pfk64bdve4